E
EnGeneIC
0 followers
EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.
Org chart
CEOs
Collapse
David Seaton
COO
Bill Harris
CFO
Nick Rengel
SVP, Business Development
Nancy Mugridge
SVP, Pharma Alliances
Ilya Sedliarou
SVP, Antibody Science
Juan Dux-Santoy
SVP, Manufacturing
Scott Pattison
VP, Translational & Clinical Operations
Joshua Barnes
VP, Clinical Research
Board & advisors
Mark Levitt
Board Member
Bryan Williams
Board Member
Bruce Stillman
Scientific Advisor
Ian Frazer
Scientific & Clinical Advisor
John Bacon
Advisor
Robert Frederick Seamark
Scientific Advisor
Kulvinder Singh Saini
Advisor